Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Immunotherapy × Tegafur × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Immunotherapy 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma 1

Interventions

tislelizumab 2 Oxaliplatin 2 apatinib 1 Tegafur 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05223088 2025-03-18

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Fujian Cancer Hospital

Phase 2 Completed

Gastrointestinal

Immunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡